Correction

Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study(Oct, 10.1007/s40744-022-00498-x, 2022)

RHEUMATOLOGY AND THERAPY (2023)

Volume 10, Issue 1, Pages 71-72

DOI: 10.1007/s40744-022-00530-0

Click your name to claim this paper and add it to your profile.